These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3229870)
21. Pharmacokinetics of nilvadipine. von Nieciecki A; Huber HJ; Stanislaus F J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S22-9. PubMed ID: 1283185 [TBL] [Abstract][Full Text] [Related]
22. Multiple-dose pharmacokinetics of nilvadipine in healthy volunteers. Terakawa M; Tokuma Y; Kuwahara N; Shishido A; Noguchi H J Clin Pharmacol; 1988 Apr; 28(4):350-5. PubMed ID: 3392233 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of triflusal after single and repeated doses in man. Ramis J; Torrent J; Mis R; Conte L; Barbanoj MJ; Jané J; Forn J Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):344-9. PubMed ID: 2272716 [TBL] [Abstract][Full Text] [Related]
24. Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipine. Cheung WK; Sia LL; Woodward DL; Graveline JF; Desjardins RE; Yacobi A; Silber BM J Clin Pharmacol; 1988 Nov; 28(11):1001-7. PubMed ID: 3243913 [TBL] [Abstract][Full Text] [Related]
25. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers. Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetics of injected cefozopran hydrochloride in healthy volunteers]. Guo WW; Shen Q; Qin YP; Wang Y; Wang L; Miao J; Nan F; Xiang J; Yu Q; Liang MZ Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):711-4. PubMed ID: 23230745 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetics of nifedipine after a single oral dose in patients with disorders of cerebral circulation]. Sarkissian MA; Akopov SE; Grigorian GS; Ordukhanian AA; Panosian AG Farmakol Toksikol; 1989; 52(4):74-8. PubMed ID: 2806535 [TBL] [Abstract][Full Text] [Related]
28. Reproducibility of nifedipine absorption from GITS tablets: comparison of single-dose pharmacokinetics using 10, 20, 40 and 60 mg nifedipine. Tateishi T; Okumura K; Orii Y; Tanaka T Int J Clin Pharmacol Ther; 2004 Jan; 42(1):58-62. PubMed ID: 14756389 [TBL] [Abstract][Full Text] [Related]
29. The effects of rifampicin on the pharmacokinetics and pharmacodynamics of orally administered nilvadipine to healthy subjects. Saima S; Furuie K; Yoshimoto H; Fukuda J; Hayashi T; Echizen H Br J Clin Pharmacol; 2002 Feb; 53(2):203-6. PubMed ID: 11851646 [TBL] [Abstract][Full Text] [Related]
30. Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease. Takata Y; Yoshizumi T; Ito Y; Kikuchi M; Ueno M; Tsukashima A; Kobayashi K; Fujishima M Eur J Clin Pharmacol; 1992; 42(5):475-9. PubMed ID: 1606993 [TBL] [Abstract][Full Text] [Related]
31. Effect of two different meals on bioavailability of nilvadipine in healthy volunteers. Terakawa M; Tokuma Y; Shishido A; Yasuda K; Noguchi H J Clin Pharmacol; 1987 Apr; 27(4):293-6. PubMed ID: 3680587 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of alfuzosin after single oral administration to healthy volunteers, of three different doses. Salva P; Bianchetti G; Morselli P; Garcia-Teresa G; Costa J Biopharm Drug Dispos; 1992 Nov; 13(8):583-90. PubMed ID: 1358243 [TBL] [Abstract][Full Text] [Related]
33. Effect of an acute dose of alcohol on the pharmacokinetics of oral nifedipine in humans. Qureshi S; Laganière S; Caillé G; Gossard D; Lacasse Y; McGilveray I Pharm Res; 1992 May; 9(5):683-6. PubMed ID: 1608903 [TBL] [Abstract][Full Text] [Related]
34. The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine. Ndanusa BU; Mustapha A; Abdu-Aguye I J Pharm Biomed Anal; 1997 Jun; 15(9-10):1571-5. PubMed ID: 9226591 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic interaction between nifedipine and propranolol. Zylber-Katz E; Turetz-Abramovitch M; Koren G; Levy M Fundam Clin Pharmacol; 1988; 2(1):29-35. PubMed ID: 3371839 [TBL] [Abstract][Full Text] [Related]
36. Nonlinear first-pass metabolism of nifedipine in healthy subjects. Schellens JH; Van Haelst IM; Houston JB; Breimer DD Xenobiotica; 1991 Apr; 21(4):547-55. PubMed ID: 1897253 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs. Tokuma Y; Sekiguchi M; Niwa T; Noguchi H Xenobiotica; 1988 Jan; 18(1):21-8. PubMed ID: 3354229 [TBL] [Abstract][Full Text] [Related]
38. Ethnic differences in the pharmacokinetics of oral nifedipine. Ahsan CH; Renwick AG; Macklin B; Challenor VF; Waller DG; George CF Br J Clin Pharmacol; 1991 Apr; 31(4):399-403. PubMed ID: 2049247 [TBL] [Abstract][Full Text] [Related]
39. A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide. Philip PA; Joel S; Monkman SC; Dolega-Ossowski E; Tonkin K; Carmichael J; Idle JR; Harris AL Br J Cancer; 1992 Feb; 65(2):267-70. PubMed ID: 1739628 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of nifedipine after oral administration in chronic liver disease. Ene MD; Roberts CJ J Clin Pharmacol; 1987 Dec; 27(12):1001-4. PubMed ID: 3437063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]